Pia E. Ringholm
Nessuna posizione attualmente
Profilo
Pia E.
Ringholm formerly worked at Zymenex A, as Quality Director from 2000 to 2011, Christian Hansen Holding A, as Manager, ALK-Abello A, as Principal, and LEO Pharma A, as Manager.
Ms. Ringholm received her graduate degree from Danmarks Farmaceutiske Universitet.
Precedenti posizioni note di Pia E. Ringholm
| Società | Posizione | Fine |
|---|---|---|
| ALK-ABELLÓ A/S | Corporate Officer/Principal | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| Christian Hansen Holding A/S | Corporate Officer/Principal | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Consigliere Generale | - |
Formazione di Pia E. Ringholm
| Danmarks Farmaceutiske Universitet | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALK-ABELLÓ A/S | Health Technology |
| Aziende private | 3 |
|---|---|
| Christian Hansen Holding A/S | Consumer Non-Durables |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Pia E. Ringholm
